Objectif "Our ITN has both scientific and therapeutic targets. Research in Work Package 1 (WP1) aims to advance understanding of normal blood cell development and why primitive cells fail to differentiate in acute myeloid leukaemia (AML). Research in WP2 will use the information gained from WP1 to develop ways of alleviating the differentiation block in AML and so deliver new agents for use in differentiation therapy. This type of therapy aims, using only mildly toxic treatments, to induce terminal maturation of leukaemia cells and accelerate their death. WP2 responds to the urgent need to devise milder treatments, especially for older and frailer AML patients. Participants have already identified a number of promising new therapeutic agents. Working across these two complementary areas will train our Early Stage Researchers (ESR) to understand the translation of new fundamental science into the development of new therapies. The ITN brings together scientists who have made important advances in the fields of haematopoiesis and differentiation therapy, so will provide an excellent scientific training in these areas. Secondments/visits by ESRs to participants who run centres of expertise in leading edge technologies will provide training in these; and the time spent with private sector participants, and the courses they provide, will ensure that ESRs acquire the transferable skills they will need if they are to work well in, and build bridges between, commercial and publicly funded research organisations. ESRs will also receive management training. This research and training, which will develop our ESRs as versatile scientists, will involve the combined efforts of prestigious research institutes and universities, Poland’s leading governmental pharmaceutical R & D institute, two successful biopharmaceutical companies and a leading management consultancy." Champ scientifique medical and health sciencesclinical medicineoncologyleukemia Programme(s) FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) Thème(s) FP7-PEOPLE-2012-ITN - Marie-Curie Action: "Initial Training Networks" Appel à propositions FP7-PEOPLE-2012-ITN Voir d’autres projets de cet appel Régime de financement MC-ITN - Networks for Initial Training (ITN) Coordinateur THE UNIVERSITY OF BIRMINGHAM Contribution de l’UE € 753 274,50 Adresse Edgbaston B15 2TT Birmingham Royaume-Uni Voir sur la carte Région West Midlands (England) West Midlands Birmingham Type d’activité Higher or Secondary Education Establishments Contact administratif May Chung (Ms.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée Participants (7) Trier par ordre alphabétique Trier par contribution de l’UE Tout développer Tout réduire UNIVERSITY OF GALWAY Irlande Contribution de l’UE € 550 419,30 Adresse UNIVERSITY ROAD H91 Galway Voir sur la carte Région Ireland Northern and Western West Type d’activité Higher or Secondary Education Establishments Contact administratif Mari Vahey (Ms.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée UNIVERSITAT BASEL Suisse Contribution de l’UE € 496 573,88 Adresse PETERSPLATZ 1 4051 Basel Voir sur la carte Région Schweiz/Suisse/Svizzera Nordwestschweiz Basel-Stadt Type d’activité Higher or Secondary Education Establishments Contact administratif Antonius Rolink (Prof.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée UNIWERSYTET WROCLAWSKI Pologne Contribution de l’UE € 249 205,66 Adresse PL UNIWERSYTECKI 1 50137 Wroclaw Voir sur la carte Région Makroregion południowo-zachodni Dolnośląskie Miasto Wrocław Type d’activité Higher or Secondary Education Establishments Contact administratif Ewa Marcinkowska (Dr.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée ORBSEN THERAPEUTICS LIMITED Irlande Contribution de l’UE € 244 814,45 Adresse UNIT 1 GALWAY BUSINESS PARK H91 Galway Voir sur la carte Région Ireland Eastern and Midland Dublin Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Contact administratif Stephen Elliman (Dr.) Liens Contacter l’organisation Opens in new window Coût total Aucune donnée INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG Royaume-Uni Contribution de l’UE € 285 056,62 Adresse OLD BROMPTON ROAD 123 SW7 3RP London Voir sur la carte Région London Inner London — West Kensington & Chelsea and Hammersmith & Fulham Type d’activité Higher or Secondary Education Establishments Contact administratif Yodry Vasquez (Mr.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée SIEC BADAWCZA LUKASIEWICZ - INSTYTUT FARMACEUTYCZNY Pologne Contribution de l’UE € 448 620,90 Adresse UL. RYDYGIERA 8 01 793 Warszawa Voir sur la carte Région Makroregion województwo mazowieckie Warszawski stołeczny Miasto Warszawa Type d’activité Other Contact administratif Andrzej Kutner (Dr.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée CELENTYX LIMITED Royaume-Uni Contribution de l’UE € 285 056,62 Adresse VINCENT DRIVE 97 B15 2SQ BIRMINGHAM Voir sur la carte Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Contact administratif Catherine Brady (Dr.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée